speb/financial-data huggingface dataset:
DNP balance_sheet (annual, 2023-10-31) — Total Capitalization: 3656663706.00
DNP balance_sheet (annual, 2023-10-31) — Total Debt: 972343493.00
DNP balance_sheet (annual, 2023-10-31) — Total Equity Gross Minority Interest: 2684320213.00
DNP balance_sheet (annual, 2023-10-31) — Total Liabilities Net Minority Interest: 1136137569.00
DNP income_statement (annual, 2024-10-31) — +Operating Expense: 8640547.00
DNP income_statement (annual, 2024-10-31) — +Total Revenue: 851710639.00
DNP balance_sheet (annual, 2024-10-31) — Accounts Payable: 30054303.00
DNP balance_sheet (quarterly, 2024-10-31) — Accounts Payable: 30054303.00
DNP balance_sheet (annual, 2024-10-31) — Additional Paid In Capital: 2455239017.00
DNP balance_sheet (quarterly, 2024-10-31) — Additional Paid In Capital: 2455239017.00
DNP balance_sheet (annual, 2024-10-31) — Available For Sale Securities: 45882396.00
DNP balance_sheet (quarterly, 2024-10-31) — Available For Sale Securities: 45882396.00
DNP income_statement (annual, 2024-10-31) — Basic Average Shares: 364965408.00
DNP income_statement (annual, 2024-10-31) — Basic EPS: 2.31
DNP cash_flow (annual, 2024-10-31) — Beginning Cash Position: 44624938.00
DNP balance_sheet (annual, 2024-10-31) — Capital Stock: 369506.00
DNP balance_sheet (quarterly, 2024-10-31) — Capital Stock: 369506.00
DNP balance_sheet (annual, 2024-10-31) — Cash And Cash Equivalents: 23573884.00
DNP balance_sheet (quarterly, 2024-10-31) — Cash And Cash Equivalents: 23573884.00
DNP balance_sheet (annual, 2024-10-31) — Cash Cash Equivalents And Federal Funds Sold: 23573884.00
DNP balance_sheet (quarterly, 2024-10-31) — Cash Cash Equivalents And Federal Funds Sold: 23573884.00
DNP cash_flow (annual, 2024-10-31) — Cash Dividends Paid: -285300326.00
DNP balance_sheet (annual, 2024-10-31) — Cash Financial: 23573884.00
DNP balance_sheet (quarterly, 2024-10-31) — Cash Financial: 23573884.00
DNP cash_flow (annual, 2024-10-31) — Change In Other Current Liabilities: 460249.00
DNP cash_flow (annual, 2024-10-31) — Change In Payable: -308556.00
DNP cash_flow (annual, 2024-10-31) — Change In Receivables: 1279734.00
DNP cash_flow (annual, 2024-10-31) — Change In Working Capital: 1431427.00
DNP cash_flow (annual, 2024-10-31) — Changes In Cash: -21051054.00
DNP balance_sheet (annual, 2024-10-31) — Common Stock: 369506.00
DNP balance_sheet (quarterly, 2024-10-31) — Common Stock: 369506.00
DNP cash_flow (annual, 2024-10-31) — Common Stock Dividend Paid: -285300326.00
DNP balance_sheet (annual, 2024-10-31) — Common Stock Equity: 3300437018.00
DNP balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: 3300437018.00
DNP cash_flow (annual, 2024-10-31) — Common Stock Issuance: 58892557.00
DNP income_statement (annual, 2024-10-31) — Diluted Average Shares: 364965408.00
DNP income_statement (annual, 2024-10-31) — Diluted EPS: 2.31
DNP income_statement (annual, 2024-10-31) — Diluted NI Availto Com Stockholders: 843070092.00
DNP cash_flow (annual, 2024-10-31) — Dividend Received Cfo: 17524670.00
DNP cash_flow (annual, 2024-10-31) — End Cash Position: 23573884.00
DNP balance_sheet (annual, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4334475582.00
DNP balance_sheet (quarterly, 2024-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4334475582.00
DNP cash_flow (annual, 2024-10-31) — Financing Cash Flow: -226500256.00
DNP cash_flow (annual, 2024-10-31) — Free Cash Flow: 205449202.00
DNP cash_flow (annual, 2024-10-31) — Gain Loss On Investment Securities: -657217505.00
DNP income_statement (annual, 2024-10-31) — Gain On Sale Of Security: 163640217.00
DNP income_statement (annual, 2024-10-31) — General And Administrative Expense: 8378772.00
DNP income_statement (annual, 2024-10-31) — Interest Expense: 61330208.00
DNP income_statement (annual, 2024-10-31) — Interest Income: 34272739.00
DNP balance_sheet (annual, 2024-10-31) — Invested Capital: 4273022243.00
DNP balance_sheet (quarterly, 2024-10-31) — Invested Capital: 4273022243.00
DNP balance_sheet (annual, 2024-10-31) — Investmentin Financial Assets: 4380357978.00
DNP balance_sheet (quarterly, 2024-10-31) — Investmentin Financial Assets: 4380357978.00
DNP balance_sheet (annual, 2024-10-31) — Investments And Advances: 4380357978.00
DNP balance_sheet (quarterly, 2024-10-31) — Investments And Advances: 4380357978.00
DNP cash_flow (annual, 2024-10-31) — Issuance Of Capital Stock: 58892557.00
DNP balance_sheet (annual, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 972585225.00
DNP balance_sheet (quarterly, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 972585225.00
DNP cash_flow (annual, 2024-10-31) — Net Common Stock Issuance: 58892557.00
DNP balance_sheet (annual, 2024-10-31) — Net Debt: 949011341.00
DNP balance_sheet (quarterly, 2024-10-31) — Net Debt: 949011341.00
DNP income_statement (annual, 2024-10-31) — Net Income: 843070092.00
DNP income_statement (annual, 2024-10-31) — Net Income Common Stockholders: 843070092.00
DNP income_statement (annual, 2024-10-31) — Net Income Continuous Operations: 843070092.00
DNP income_statement (annual, 2024-10-31) — Net Income From Continuing And Discontinued Operation: 843070092.00
DNP income_statement (annual, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: 843070092.00
DNP cash_flow (annual, 2024-10-31) — Net Income From Continuing Operations: 843070092.00
DNP income_statement (annual, 2024-10-31) — Net Income Including Noncontrolling Interests: 843070092.00
DNP income_statement (annual, 2024-10-31) — Net Interest Income: -27057469.00
DNP cash_flow (annual, 2024-10-31) — Net Other Financing Charges: 0.00
DNP balance_sheet (annual, 2024-10-31) — Net Tangible Assets: 3300437018.00
DNP balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: 3300437018.00
DNP income_statement (annual, 2024-10-31) — Normalized Income: 843070092.00
DNP cash_flow (annual, 2024-10-31) — Operating Cash Flow: 205449202.00
DNP income_statement (annual, 2024-10-31) — Operating Revenue: 851710639.00
DNP balance_sheet (annual, 2024-10-31) — Ordinary Shares Number: 369505594.00
DNP balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 369505594.00
DNP cash_flow (annual, 2024-10-31) — Other Non Cash Items: 640518.00
DNP income_statement (annual, 2024-10-31) — Other Operating Expenses: 261775.00
DNP balance_sheet (annual, 2024-10-31) — Other Payable: 2473327.00
DNP balance_sheet (quarterly, 2024-10-31) — Other Payable: 2473327.00
DNP balance_sheet (annual, 2024-10-31) — Payables: 32527630.00
DNP balance_sheet (quarterly, 2024-10-31) — Payables: 32527630.00
DNP balance_sheet (annual, 2024-10-31) — Preferred Securities Outside Stock Equity: 131749259.00
DNP balance_sheet (quarterly, 2024-10-31) — Preferred Securities Outside Stock Equity: 131749259.00
DNP balance_sheet (annual, 2024-10-31) — Prepaid Assets: 145360.00
DNP balance_sheet (quarterly, 2024-10-31) — Prepaid Assets: 145360.00
DNP income_statement (annual, 2024-10-31) — Pretax Income: 843070092.00
DNP balance_sheet (annual, 2024-10-31) — Receivables: 33322767.00
DNP balance_sheet (quarterly, 2024-10-31) — Receivables: 33322767.00
DNP balance_sheet (annual, 2024-10-31) — Retained Earnings: 844828495.00
DNP balance_sheet (quarterly, 2024-10-31) — Retained Earnings: 844828495.00
DNP income_statement (annual, 2024-10-31) — Selling General And Administration: 8378772.00
DNP balance_sheet (annual, 2024-10-31) — Share Issued: 369505594.00
DNP balance_sheet (quarterly, 2024-10-31) — Share Issued: 369505594.00
DNP balance_sheet (annual, 2024-10-31) — Stockholders Equity: 3300437018.00
DNP balance_sheet (quarterly, 2024-10-31) — Stockholders Equity: 3300437018.00
DNP balance_sheet (annual, 2024-10-31) — Tangible Book Value: 3300437018.00
DNP balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: 3300437018.00
DNP income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
DNP income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.21
DNP balance_sheet (annual, 2024-10-31) — Total Assets: 4437399989.00
DNP balance_sheet (quarterly, 2024-10-31) — Total Assets: 4437399989.00
DNP balance_sheet (annual, 2024-10-31) — Total Capitalization: 4273022243.00
DNP balance_sheet (quarterly, 2024-10-31) — Total Capitalization: 4273022243.00
DNP balance_sheet (annual, 2024-10-31) — Total Debt: 972585225.00
DNP balance_sheet (quarterly, 2024-10-31) — Total Debt: 972585225.00
DNP balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: 3300437018.00
DNP balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: 3300437018.00
DNP balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 1136962971.00
DNP balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 1136962971.00
DNP balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 29789000.00
DNP balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 2483966000.00
DNP balance_sheet (quarterly, 2025-04-30) — Available For Sale Securities: 18985000.00
DNP balance_sheet (quarterly, 2025-04-30) — Capital Stock: 373000.00
DNP balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 28139000.00
DNP balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Federal Funds Sold: 28139000.00
DNP balance_sheet (quarterly, 2025-04-30) — Cash Financial: 28139000.00
DNP balance_sheet (quarterly, 2025-04-30) — Common Stock: 373000.00
DNP balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 3457122000.00
DNP balance_sheet (quarterly, 2025-04-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4532012000.00
DNP balance_sheet (quarterly, 2025-04-30) — Invested Capital: 4429827000.00
DNP balance_sheet (quarterly, 2025-04-30) — Investmentin Financial Assets: 4550997000.00
DNP balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 4550997000.00
DNP balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 972705000.00
DNP balance_sheet (quarterly, 2025-04-30) — Net Debt: 944566000.00
DNP balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 3457122000.00
DNP balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 372706845.00
DNP balance_sheet (quarterly, 2025-04-30) — Other Payable: 2326000.00
DNP balance_sheet (quarterly, 2025-04-30) — Payables: 32115000.00
DNP balance_sheet (quarterly, 2025-04-30) — Preferred Securities Outside Stock Equity: 131801000.00
DNP balance_sheet (quarterly, 2025-04-30) — Preferred Shares Number: 1320.00
DNP balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 310000.00
DNP balance_sheet (quarterly, 2025-04-30) — Receivables: 13670000.00
DNP balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 972783000.00
DNP balance_sheet (quarterly, 2025-04-30) — Share Issued: 372706845.00
DNP balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 3457122000.00
DNP balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 3457122000.00
DNP balance_sheet (quarterly, 2025-04-30) — Taxes Receivable: 1036000.00
DNP balance_sheet (quarterly, 2025-04-30) — Total Assets: 4594152000.00
DNP balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 4429827000.00
DNP balance_sheet (quarterly, 2025-04-30) — Total Debt: 972705000.00
DNP balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 3457122000.00
DNP balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 1137030000.00
DNP income_statement (annual, 2025-10-31) — +Operating Expense: 8199000.00
DNP income_statement (annual, 2025-10-31) — +Total Revenue: 438812000.00
DNP balance_sheet (annual, 2025-10-31) — Accounts Payable: 30037000.00
DNP balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 30037000.00
DNP balance_sheet (annual, 2025-10-31) — Additional Paid In Capital: 2448498000.00
DNP balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 2448498000.00
DNP cash_flow (annual, 2025-10-31) — Beginning Cash Position: 23574000.00
DNP balance_sheet (annual, 2025-10-31) — Capital Stock: 376000.00
DNP balance_sheet (quarterly, 2025-10-31) — Capital Stock: 376000.00
DNP balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 26584000.00
DNP balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 26584000.00
DNP balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Federal Funds Sold: 26584000.00
DNP balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Federal Funds Sold: 26584000.00
DNP cash_flow (annual, 2025-10-31) — Cash Dividends Paid: -232869000.00
DNP balance_sheet (annual, 2025-10-31) — Cash Financial: 26584000.00
DNP balance_sheet (quarterly, 2025-10-31) — Cash Financial: 26584000.00
DNP cash_flow (annual, 2025-10-31) — Change In Other Current Liabilities: 0.00
DNP cash_flow (annual, 2025-10-31) — Change In Payable: 7000.00
DNP cash_flow (annual, 2025-10-31) — Change In Prepaid Assets: 123000.00
DNP cash_flow (annual, 2025-10-31) — Change In Receivables: 16169000.00
DNP cash_flow (annual, 2025-10-31) — Change In Working Capital: 16299000.00
DNP cash_flow (annual, 2025-10-31) — Changes In Cash: 3010000.00
DNP balance_sheet (annual, 2025-10-31) — Common Stock: 376000.00
DNP balance_sheet (quarterly, 2025-10-31) — Common Stock: 376000.00
DNP cash_flow (annual, 2025-10-31) — Common Stock Dividend Paid: -232869000.00
DNP balance_sheet (annual, 2025-10-31) — Common Stock Equity: 3497770000.00
DNP balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 3497770000.00
DNP income_statement (annual, 2025-10-31) — Diluted Average Shares: 371218103.00
DNP income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 430613000.00
DNP cash_flow (annual, 2025-10-31) — Dividend Received Cfo: 16555000.00
DNP cash_flow (annual, 2025-10-31) — End Cash Position: 26584000.00
DNP balance_sheet (annual, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4591736000.00
DNP balance_sheet (quarterly, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 4591736000.00
DNP cash_flow (annual, 2025-10-31) — Financing Cash Flow: -232869000.00
DNP cash_flow (annual, 2025-10-31) — Free Cash Flow: 235879000.00
DNP cash_flow (annual, 2025-10-31) — Gain Loss On Investment Securities: -230178000.00
DNP income_statement (annual, 2025-10-31) — Gain On Sale Of Security: 170173000.00
DNP income_statement (annual, 2025-10-31) — General And Administrative Expense: 7974000.00
DNP income_statement (annual, 2025-10-31) — Interest Expense: 54091000.00
DNP income_statement (annual, 2025-10-31) — Interest Income: 36100000.00
DNP balance_sheet (annual, 2025-10-31) — Invested Capital: 4470596000.00
DNP balance_sheet (quarterly, 2025-10-31) — Invested Capital: 4470596000.00
DNP balance_sheet (annual, 2025-10-31) — Investmentin Financial Assets: 4591736000.00
DNP balance_sheet (quarterly, 2025-10-31) — Investmentin Financial Assets: 4591736000.00
DNP balance_sheet (annual, 2025-10-31) — Investments And Advances: 4591736000.00
DNP balance_sheet (quarterly, 2025-10-31) — Investments And Advances: 4591736000.00
DNP balance_sheet (annual, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 972826000.00
DNP balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 972826000.00
DNP balance_sheet (annual, 2025-10-31) — Net Debt: 946242000.00
DNP balance_sheet (quarterly, 2025-10-31) — Net Debt: 946242000.00
DNP income_statement (annual, 2025-10-31) — Net Income: 430613000.00
DNP income_statement (annual, 2025-10-31) — Net Income Common Stockholders: 430613000.00
DNP income_statement (annual, 2025-10-31) — Net Income Continuous Operations: 430613000.00
DNP income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 430613000.00
DNP income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 430613000.00
DNP cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: 430613000.00
DNP income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: 430613000.00
DNP income_statement (annual, 2025-10-31) — Net Interest Income: -17991000.00
DNP cash_flow (annual, 2025-10-31) — Net Other Financing Charges: 0.00
DNP balance_sheet (annual, 2025-10-31) — Net Tangible Assets: 3497770000.00
DNP balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 3497770000.00
DNP income_statement (annual, 2025-10-31) — Normalized Income: 430613000.00
DNP cash_flow (annual, 2025-10-31) — Operating Cash Flow: 235879000.00
DNP income_statement (annual, 2025-10-31) — Operating Revenue: 438812000.00
DNP balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 375804183.00
DNP balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 375804183.00
DNP cash_flow (annual, 2025-10-31) — Other Non Cash Items: 2232000.00
DNP income_statement (annual, 2025-10-31) — Other Operating Expenses: 225000.00
DNP balance_sheet (annual, 2025-10-31) — Other Payable: 2485000.00
DNP balance_sheet (quarterly, 2025-10-31) — Other Payable: 2485000.00
DNP balance_sheet (annual, 2025-10-31) — Payables: 32522000.00
DNP balance_sheet (quarterly, 2025-10-31) — Payables: 32522000.00
DNP balance_sheet (annual, 2025-10-31) — Preferred Securities Outside Stock Equity: 131853000.00
DNP balance_sheet (quarterly, 2025-10-31) — Preferred Securities Outside Stock Equity: 131853000.00
DNP balance_sheet (annual, 2025-10-31) — Preferred Shares Number: 1320.00
DNP balance_sheet (quarterly, 2025-10-31) — Preferred Shares Number: 1320.00
DNP balance_sheet (annual, 2025-10-31) — Prepaid Assets: 22000.00
DNP balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 22000.00
DNP income_statement (annual, 2025-10-31) — Pretax Income: 430613000.00
DNP balance_sheet (annual, 2025-10-31) — Receivables: 15356000.00
DNP balance_sheet (quarterly, 2025-10-31) — Receivables: 15356000.00
DNP balance_sheet (annual, 2025-10-31) — Retained Earnings: 1048896000.00
DNP balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 1048896000.00
DNP income_statement (annual, 2025-10-31) — Selling General And Administration: 7974000.00
DNP balance_sheet (annual, 2025-10-31) — Share Issued: 375804183.00
DNP balance_sheet (quarterly, 2025-10-31) — Share Issued: 375804183.00
DNP balance_sheet (annual, 2025-10-31) — Stockholders Equity: 3497770000.00
DNP balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 3497770000.00
DNP balance_sheet (annual, 2025-10-31) — Tangible Book Value: 3497770000.00
DNP balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 3497770000.00
DNP income_statement (annual, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
DNP income_statement (annual, 2025-10-31) — Tax Rate For Calcs: 0.21
DNP balance_sheet (annual, 2025-10-31) — Taxes Receivable: 1798000.00
DNP balance_sheet (quarterly, 2025-10-31) — Taxes Receivable: 1798000.00
DNP balance_sheet (annual, 2025-10-31) — Total Assets: 4635496000.00
DNP balance_sheet (quarterly, 2025-10-31) — Total Assets: 4635496000.00
DNP balance_sheet (annual, 2025-10-31) — Total Capitalization: 4470596000.00
DNP balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 4470596000.00
DNP balance_sheet (annual, 2025-10-31) — Total Debt: 972826000.00
DNP balance_sheet (quarterly, 2025-10-31) — Total Debt: 972826000.00
DNP balance_sheet (annual, 2025-10-31) — Total Equity Gross Minority Interest: 3497770000.00
DNP balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 3497770000.00
DNP balance_sheet (annual, 2025-10-31) — Total Liabilities Net Minority Interest: 1137726000.00
DNP balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 1137726000.00
DNTH income_statement (annual, 2021-12-31) — Basic Average Shares: 14817700.00
DNTH income_statement (annual, 2021-12-31) — Basic EPS: -0.88
DNTH balance_sheet (annual, 2021-12-31) — Construction In Progress: 33000.00
DNTH income_statement (annual, 2021-12-31) — Diluted Average Shares: 14817700.00
DNTH income_statement (annual, 2021-12-31) — Diluted EPS: -0.88
DNTH cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 15000000.00
DNTH balance_sheet (annual, 2021-12-31) — Other Receivables: 1007000.00
DNTH balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 21348000.00
DNTH cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 15000000.00
DNTH income_statement (annual, 2022-12-31) — +Operating Expense: 36122000.00
DNTH income_statement (annual, 2022-12-31) — +Total Revenue: 6417000.00
DNTH balance_sheet (annual, 2022-12-31) — Accounts Payable: 1167000.00
DNTH balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -30000.00
DNTH balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1661000.00
DNTH cash_flow (annual, 2022-12-31) — Amortization Of Securities: -606000.00
DNTH income_statement (annual, 2022-12-31) — Basic Average Shares: 14817700.00
DNTH income_statement (annual, 2022-12-31) — Basic EPS: -1.92
DNTH cash_flow (annual, 2022-12-31) — Beginning Cash Position: 7638000.00
DNTH cash_flow (annual, 2022-12-31) — Capital Expenditure: -139000.00
DNTH cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -139000.00
DNTH balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 788000.00
DNTH balance_sheet (annual, 2022-12-31) — Capital Stock: 118024000.00
DNTH balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 15365000.00
DNTH balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 75490000.00
DNTH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 96676000.00
DNTH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -59819000.00
DNTH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -29070000.00
DNTH cash_flow (annual, 2022-12-31) — Change In Account Payable: 2280000.00
DNTH cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -31000.00
DNTH cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 891000.00
DNTH cash_flow (annual, 2022-12-31) — Change In Payable: 2280000.00
DNTH cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 2280000.00
DNTH cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -631000.00
DNTH cash_flow (annual, 2022-12-31) — Change In Receivables: -4162000.00
DNTH cash_flow (annual, 2022-12-31) — Change In Working Capital: -1653000.00
DNTH cash_flow (annual, 2022-12-31) — Changes In Cash: 7787000.00
DNTH balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
DNTH balance_sheet (annual, 2022-12-31) — Common Stock Equity: -44368000.00
DNTH cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
DNTH balance_sheet (annual, 2022-12-31) — Construction In Progress: 0.00
DNTH balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 4524000.00
DNTH balance_sheet (annual, 2022-12-31) — Current Assets: 82033000.00
DNTH balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 350000.00
DNTH balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 350000.00
DNTH balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 100000.00
DNTH balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 100000.00
DNTH balance_sheet (annual, 2022-12-31) — Current Liabilities: 8225000.00
DNTH cash_flow (annual, 2022-12-31) — Depreciation: 147000.00
DNTH cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 147000.00
DNTH cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 147000.00
DNTH income_statement (annual, 2022-12-31) — Diluted Average Shares: 14817700.00
DNTH income_statement (annual, 2022-12-31) — Diluted EPS: -1.92
DNTH income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -28476000.00
DNTH balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 4700000.00
DNTH income_statement (annual, 2022-12-31) — EBIT: -29705000.00
DNTH income_statement (annual, 2022-12-31) — EBITDA: -29558000.00
DNTH cash_flow (annual, 2022-12-31) — End Cash Position: 15425000.00
DNTH cash_flow (annual, 2022-12-31) — Financing Cash Flow: 96676000.00
DNTH cash_flow (annual, 2022-12-31) — Free Cash Flow: -29209000.00
DNTH income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 136000.00
DNTH balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -161000.00
DNTH income_statement (annual, 2022-12-31) — General And Administrative Expense: 6743000.00
DNTH balance_sheet (annual, 2022-12-31) — Gross PPE: 986000.00
DNTH cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
DNTH income_statement (annual, 2022-12-31) — Interest Income: 1145000.00
DNTH income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1145000.00
DNTH cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
DNTH balance_sheet (annual, 2022-12-31) — Invested Capital: -44368000.00
DNTH cash_flow (annual, 2022-12-31) — Investing Cash Flow: -59819000.00
DNTH cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 100000000.00
DNTH cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
DNTH balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 438000.00
DNTH balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 438000.00
DNTH cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
DNTH cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
DNTH balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 172000.00
DNTH cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
DNTH income_statement (annual, 2022-12-31) — Net Income: -28476000.00
DNTH income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -28476000.00
DNTH income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -28476000.00
DNTH income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -28476000.00
DNTH income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -28476000.00
DNTH cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -28476000.00
DNTH income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -28476000.00
DNTH income_statement (annual, 2022-12-31) — Net Interest Income: 1145000.00
DNTH cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -59680000.00
DNTH cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
DNTH cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
DNTH income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1145000.00
DNTH cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -3324000.00
DNTH balance_sheet (annual, 2022-12-31) — Net PPE: 956000.00
DNTH cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 100000000.00
DNTH balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 73656000.00
DNTH balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 791000.00
DNTH balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 791000.00
DNTH income_statement (annual, 2022-12-31) — Normalized EBITDA: -29694000.00
DNTH income_statement (annual, 2022-12-31) — Normalized Income: -28612000.00
DNTH cash_flow (annual, 2022-12-31) — Operating Cash Flow: -29070000.00
DNTH income_statement (annual, 2022-12-31) — Operating Income: -29705000.00
DNTH income_statement (annual, 2022-12-31) — Operating Revenue: 6417000.00
DNTH balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 14817700.00
DNTH balance_sheet (annual, 2022-12-31) — Other Current Assets: 53000.00
DNTH balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -161000.00
DNTH income_statement (annual, 2022-12-31) — Other Gand A: 6743000.00
DNTH income_statement (annual, 2022-12-31) — Other Income Expense: 84000.00
DNTH balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 121000.00
DNTH income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -52000.00
DNTH balance_sheet (annual, 2022-12-31) — Other Properties: 814000.00
DNTH balance_sheet (annual, 2022-12-31) — Other Receivables: 938000.00
DNTH balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 60125000.00
DNTH balance_sheet (annual, 2022-12-31) — Payables: 1167000.00
DNTH balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 5691000.00
DNTH balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2084000.00
DNTH balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 21348000.00
DNTH balance_sheet (annual, 2022-12-31) — Preferred Stock: 118024000.00
DNTH balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 118024000.00
DNTH cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 100000000.00
DNTH balance_sheet (annual, 2022-12-31) — Prepaid Assets: 852000.00
DNTH income_statement (annual, 2022-12-31) — Pretax Income: -28476000.00
DNTH cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
DNTH cash_flow (annual, 2022-12-31) — Purchase Of Investment: -61680000.00
DNTH balance_sheet (annual, 2022-12-31) — Receivables: 5638000.00
DNTH income_statement (annual, 2022-12-31) — Reconciled Depreciation: 147000.00
DNTH cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
DNTH income_statement (annual, 2022-12-31) — Research And Development: 29379000.00
DNTH balance_sheet (annual, 2022-12-31) — Retained Earnings: -45868000.00
DNTH cash_flow (annual, 2022-12-31) — Sale Of Investment: 2000000.00
DNTH income_statement (annual, 2022-12-31) — Selling General And Administration: 6743000.00
DNTH balance_sheet (annual, 2022-12-31) — Share Issued: 14817700.00
DNTH cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1518000.00
DNTH balance_sheet (annual, 2022-12-31) — Stockholders Equity: 73656000.00
DNTH balance_sheet (annual, 2022-12-31) — Tangible Book Value: -44368000.00
DNTH income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
DNTH income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
DNTH balance_sheet (annual, 2022-12-31) — Total Assets: 83110000.00
DNTH balance_sheet (annual, 2022-12-31) — Total Capitalization: 73656000.00
DNTH balance_sheet (annual, 2022-12-31) — Total Debt: 788000.00
DNTH balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 73656000.00
DNTH income_statement (annual, 2022-12-31) — Total Expenses: 36122000.00
DNTH balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 9454000.00
DNTH balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1077000.00
DNTH balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1229000.00
DNTH income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -29705000.00
DNTH income_statement (annual, 2022-12-31) — Total Unusual Items: 136000.00
DNTH income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 136000.00
DNTH balance_sheet (annual, 2022-12-31) — Working Capital: 73808000.00
DNTH income_statement (annual, 2023-12-31) — +Operating Expense: 51000000.00
DNTH income_statement (annual, 2023-12-31) — +Total Revenue: 2826000.00
DNTH balance_sheet (annual, 2023-12-31) — Accounts Payable: 2610000.00
DNTH balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -97000.00
DNTH balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 258231000.00
DNTH cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1423000.00
DNTH income_statement (annual, 2023-12-31) — Basic Average Shares: 5153711.00
DNTH income_statement (annual, 2023-12-31) — Basic EPS: -8.45
DNTH cash_flow (annual, 2023-12-31) — Beginning Cash Position: 15425000.00
DNTH cash_flow (annual, 2023-12-31) — Capital Expenditure: -110000.00
DNTH cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -110000.00
DNTH balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 585000.00
DNTH balance_sheet (annual, 2023-12-31) — Capital Stock: 15000.00
DNTH balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 132325000.00
DNTH balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 173718000.00
DNTH cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 133574000.00
DNTH cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 20253000.00
DNTH cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -36861000.00
DNTH cash_flow (annual, 2023-12-31) — Change In Account Payable: 661000.00
DNTH cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -1027000.00
DNTH cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -55000.00
DNTH cash_flow (annual, 2023-12-31) — Change In Payable: 661000.00
DNTH cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 661000.00
DNTH cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 123000.00
DNTH cash_flow (annual, 2023-12-31) — Change In Receivables: 5160000.00
DNTH cash_flow (annual, 2023-12-31) — Change In Working Capital: 4862000.00
DNTH cash_flow (annual, 2023-12-31) — Changes In Cash: 116966000.00
DNTH balance_sheet (annual, 2023-12-31) — Common Stock: 15000.00
DNTH balance_sheet (annual, 2023-12-31) — Common Stock Equity: 168870000.00
DNTH cash_flow (annual, 2023-12-31) — Common Stock Issuance: 72000000.00
DNTH balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1143000.00
DNTH balance_sheet (annual, 2023-12-31) — Current Assets: 177451000.00
DNTH balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 417000.00
DNTH balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 417000.00
DNTH balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 100000.00
DNTH balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 100000.00
DNTH balance_sheet (annual, 2023-12-31) — Current Liabilities: 9631000.00
DNTH cash_flow (annual, 2023-12-31) — Depreciation: 355000.00
DNTH cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 355000.00
DNTH cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 355000.00
DNTH income_statement (annual, 2023-12-31) — Diluted Average Shares: 5153711.00
DNTH income_statement (annual, 2023-12-31) — Diluted EPS: -8.45
DNTH income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -43555000.00
DNTH balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 294000.00
DNTH income_statement (annual, 2023-12-31) — EBIT: -48174000.00
DNTH income_statement (annual, 2023-12-31) — EBITDA: -47819000.00
DNTH cash_flow (annual, 2023-12-31) — End Cash Position: 132391000.00
DNTH cash_flow (annual, 2023-12-31) — Financing Cash Flow: 133574000.00
DNTH cash_flow (annual, 2023-12-31) — Free Cash Flow: -36971000.00
DNTH income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -85000.00
DNTH balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 47000.00
DNTH income_statement (annual, 2023-12-31) — General And Administrative Expense: 18159000.00
DNTH balance_sheet (annual, 2023-12-31) — Gross PPE: 897000.00
DNTH cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
DNTH income_statement (annual, 2023-12-31) — Interest Income: 4764000.00
DNTH income_statement (annual, 2023-12-31) — Interest Income Non Operating: 4764000.00
DNTH cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
DNTH balance_sheet (annual, 2023-12-31) — Invested Capital: 168870000.00
DNTH cash_flow (annual, 2023-12-31) — Investing Cash Flow: 20253000.00
DNTH balance_sheet (annual, 2023-12-31) — Investments And Advances: 0.00
DNTH cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 72000000.00
DNTH cash_flow (annual, 2023-12-31) — Issuance Of Debt: 377000.00
DNTH balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 168000.00
DNTH balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 168000.00
DNTH cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 377000.00
DNTH cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -377000.00
DNTH balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 282000.00
DNTH cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 72000000.00
DNTH income_statement (annual, 2023-12-31) — Net Income: -43555000.00
DNTH income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -43555000.00
DNTH income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -43555000.00
DNTH income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -43555000.00
DNTH income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -43555000.00
DNTH cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -43555000.00
DNTH income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -43555000.00
DNTH income_statement (annual, 2023-12-31) — Net Interest Income: 4764000.00
DNTH cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 20363000.00
DNTH cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
DNTH cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
DNTH income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 4764000.00
DNTH cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 61569000.00
DNTH balance_sheet (annual, 2023-12-31) — Net PPE: 800000.00
DNTH cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
DNTH balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 168870000.00
DNTH balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 736000.00
DNTH balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 736000.00
DNTH income_statement (annual, 2023-12-31) — Normalized EBITDA: -47734000.00
DNTH income_statement (annual, 2023-12-31) — Normalized Income: -43470000.00
DNTH cash_flow (annual, 2023-12-31) — Operating Cash Flow: -36861000.00
DNTH income_statement (annual, 2023-12-31) — Operating Income: -48174000.00
DNTH income_statement (annual, 2023-12-31) — Operating Revenue: 2826000.00
DNTH balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 14817696.00
DNTH balance_sheet (annual, 2023-12-31) — Other Current Assets: 504000.00
DNTH balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 47000.00
DNTH income_statement (annual, 2023-12-31) — Other Gand A: 18159000.00
DNTH income_statement (annual, 2023-12-31) — Other Income Expense: -145000.00
DNTH balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1154000.00
DNTH income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -60000.00
DNTH balance_sheet (annual, 2023-12-31) — Other Properties: 615000.00
DNTH balance_sheet (annual, 2023-12-31) — Other Receivables: 184000.00
DNTH balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 41393000.00
DNTH balance_sheet (annual, 2023-12-31) — Payables: 2610000.00
DNTH balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 3753000.00
DNTH balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5361000.00
DNTH balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
DNTH cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
DNTH balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2751000.00
DNTH income_statement (annual, 2023-12-31) — Pretax Income: -43555000.00
DNTH cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 5000.00
DNTH cash_flow (annual, 2023-12-31) — Purchase Of Investment: -57422000.00
DNTH balance_sheet (annual, 2023-12-31) — Receivables: 478000.00
DNTH income_statement (annual, 2023-12-31) — Reconciled Depreciation: 355000.00
DNTH cash_flow (annual, 2023-12-31) — Repayment Of Debt: -377000.00
DNTH income_statement (annual, 2023-12-31) — Research And Development: 32841000.00
DNTH balance_sheet (annual, 2023-12-31) — Retained Earnings: -89423000.00
DNTH cash_flow (annual, 2023-12-31) — Sale Of Investment: 77785000.00
DNTH income_statement (annual, 2023-12-31) — Selling General And Administration: 18159000.00
DNTH balance_sheet (annual, 2023-12-31) — Share Issued: 14817696.00
DNTH cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2900000.00
DNTH balance_sheet (annual, 2023-12-31) — Stockholders Equity: 168870000.00
DNTH balance_sheet (annual, 2023-12-31) — Tangible Book Value: 168870000.00
DNTH income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
DNTH income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
DNTH balance_sheet (annual, 2023-12-31) — Total Assets: 179405000.00
DNTH balance_sheet (annual, 2023-12-31) — Total Capitalization: 168870000.00
DNTH balance_sheet (annual, 2023-12-31) — Total Debt: 585000.00
DNTH balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 168870000.00
DNTH income_statement (annual, 2023-12-31) — Total Expenses: 51000000.00
DNTH balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 10535000.00
DNTH balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1954000.00
DNTH balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 904000.00
DNTH income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -48174000.00
DNTH income_statement (annual, 2023-12-31) — Total Unusual Items: -85000.00
DNTH income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -85000.00
DNTH balance_sheet (annual, 2023-12-31) — Working Capital: 167820000.00
DNTH cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
DNTH cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
DNTH cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
DNTH cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
DNTH cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
DNTH cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
DNTH balance_sheet (quarterly, 2024-09-30) — Other Receivables: 1293000.00
DNTH cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
DNTH income_statement (annual, 2024-12-31) — +Operating Expense: 108099000.00
DNTH income_statement (annual, 2024-12-31) — +Total Revenue: 6235000.00
DNTH balance_sheet (annual, 2024-12-31) — Accounts Payable: 4579000.00
DNTH balance_sheet (annual, 2024-12-31) — Accounts Receivable: 0.00
DNTH balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -193000.00
DNTH balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 526732000.00
DNTH cash_flow (annual, 2024-12-31) — Amortization Of Securities: -6018000.00
DNTH balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 81728000.00
DNTH income_statement (annual, 2024-12-31) — Basic Average Shares: 33313849.00
DNTH income_statement (annual, 2024-12-31) — Basic EPS: -2.55
DNTH cash_flow (annual, 2024-12-31) — Beginning Cash Position: 132391000.00
DNTH cash_flow (annual, 2024-12-31) — Capital Expenditure: -105000.00
DNTH cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -105000.00
DNTH balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1491000.00
DNTH balance_sheet (annual, 2024-12-31) — Capital Stock: 31000.00
DNTH balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 22792000.00
DNTH balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 275241000.00
DNTH cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 255623000.00
DNTH cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -286812000.00
DNTH cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -78180000.00
DNTH cash_flow (annual, 2024-12-31) — Change In Account Payable: 8191000.00
DNTH cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -8163000.00
DNTH cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 1551000.00
DNTH cash_flow (annual, 2024-12-31) — Change In Payable: 8191000.00
DNTH cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 8191000.00
DNTH cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -1601000.00
DNTH cash_flow (annual, 2024-12-31) — Change In Receivables: -329000.00
DNTH cash_flow (annual, 2024-12-31) — Change In Working Capital: -351000.00
DNTH cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 0.00
DNTH cash_flow (annual, 2024-12-31) — Changes In Cash: -109369000.00
DNTH balance_sheet (annual, 2024-12-31) — Common Stock: 31000.00
DNTH balance_sheet (annual, 2024-12-31) — Common Stock Equity: 352477000.00
DNTH cash_flow (annual, 2024-12-31) — Common Stock Issuance: 269198000.00
DNTH balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 7920000.00
DNTH balance_sheet (annual, 2024-12-31) — Current Assets: 280904000.00
DNTH balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 320000.00
DNTH balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 320000.00
DNTH balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 479000.00
DNTH balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 479000.00
DNTH balance_sheet (annual, 2024-12-31) — Current Liabilities: 18452000.00
DNTH cash_flow (annual, 2024-12-31) — Depreciation: 412000.00
DNTH cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 412000.00
DNTH cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 412000.00
DNTH income_statement (annual, 2024-12-31) — Diluted Average Shares: 33313849.00
DNTH income_statement (annual, 2024-12-31) — Diluted EPS: -2.55
DNTH income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -84969000.00
DNTH balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 807000.00
DNTH balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 807000.00
DNTH income_statement (annual, 2024-12-31) — EBIT: -101864000.00
DNTH income_statement (annual, 2024-12-31) — EBITDA: -101452000.00
DNTH cash_flow (annual, 2024-12-31) — End Cash Position: 23022000.00
DNTH cash_flow (annual, 2024-12-31) — Financing Cash Flow: 255623000.00
DNTH cash_flow (annual, 2024-12-31) — Free Cash Flow: -78285000.00
DNTH cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -148000.00
DNTH income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 84000.00
DNTH balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 106000.00
DNTH income_statement (annual, 2024-12-31) — General And Administrative Expense: 24994000.00
DNTH balance_sheet (annual, 2024-12-31) — Gross PPE: 1940000.00
DNTH cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
DNTH income_statement (annual, 2024-12-31) — Interest Income: 17365000.00
DNTH income_statement (annual, 2024-12-31) — Interest Income Non Operating: 17365000.00
DNTH cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
DNTH balance_sheet (annual, 2024-12-31) — Invested Capital: 352477000.00
DNTH cash_flow (annual, 2024-12-31) — Investing Cash Flow: -286812000.00
DNTH balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 81728000.00
DNTH balance_sheet (annual, 2024-12-31) — Investments And Advances: 81728000.00
DNTH cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 269198000.00
DNTH cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
DNTH cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
DNTH balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1171000.00
DNTH balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1171000.00
DNTH cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
DNTH cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
DNTH cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
DNTH cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
DNTH balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 387000.00
DNTH cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 269198000.00
DNTH income_statement (annual, 2024-12-31) — Net Income: -84969000.00
DNTH income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -84969000.00
DNTH income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -84969000.00
DNTH income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -84969000.00
DNTH income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -84969000.00
DNTH cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -84969000.00